v3.26.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 92,387 $ 89,213
Restricted cash 12,546 12,360
Accounts receivable, net of allowance for credit losses of $1,280 and $2,617, respectively 84,780 76,339
Inventories 239,868 225,022
Assets held for sale and discontinued operations 3,410 3,681
Prepaid expenses and other current assets 25,308 37,379
Notes receivable - current 5,358 4,629
Total current assets 463,657 448,623
Deferred tax asset 465 443
Income tax receivable 94 2,382
Other assets - net of current 19,499 13,396
Notes receivable - net of current 836 2,980
Property, plant and equipment, net 501,055 520,386
Right-of-use assets, finance lease, net 104,558 97,599
Right-of-use assets, operating lease, net 123,925 113,274
Intangible assets, net 940,759 1,011,115
Goodwill 638,287 635,117
Total assets 2,793,135 2,845,315
Current liabilities:    
Accounts payable 64,005 74,725
Accrued expenses 97,285 110,493
Income tax payable 12,114 18,952
Lease liabilities, finance - current 16,235 11,684
Lease liabilities, operating - current 21,754 19,837
Notes payable - current 46,053 35,730
Deferred consideration liability - current 7,203 2,966
Financial obligations - current 10,085 7,238
Liabilities associated with assets held for sale and discontinued operations 1,845 7,073
Other current liabilities 11,236 5,616
Total current liabilities 287,815 294,314
Deferred tax liability 131,056 212,002
Notes payable - net of current 583,427 512,922
Lease liabilities, finance - net of current 149,646 144,446
Lease liabilities, operating - net of current 111,358 102,346
Uncertain tax position 476,092 531,508
Contingent consideration liability - net of current 3,666 3,358
Financial obligations - net of current 192,765 202,901
Other non-current liabilities 10,285 1,237
Total liabilities 1,946,110 2,005,034
Commitments and contingencies
Temporary equity:    
Redeemable non-controlling interest contingency 0 83,931
Shareholders’ equity:    
Common stock, no par value; unlimited shares authorized; 264,984,190 and 257,491,582 shares issued and outstanding as of September 30, 2026 and December 31, 2025, respectively. 0 0
Additional paid-in capital 2,398,807 2,345,402
Accumulated other comprehensive loss (14,123) (1,808)
Accumulated deficit (1,537,659) (1,587,244)
Total shareholders’ equity 847,025 756,350
Total liabilities, temporary equity and shareholders’ equity $ 2,793,135 $ 2,845,315